Skip to content
Screener

AngioDynamics ANGO Med Device — Net Sales

Other product segments

Med Tech
$41.76M

Similar metrics at other companies

Amazon logo
AMZNNet service sales — Net Sales
$110.22B+20.2%
Otis Worldwide logo
OTISService sales — Net Sales
$2.58B+11.3%
Lowe's Companies logo
LOWService — Net Sales
$706M+29.8%
Home Depot logo
HDService — Net Sales
$1.33B-1.1%
KVH Industries logo
KVHIService — Net Sales
$29.71M+28.9%
Axon Enterprise, Inc. logo
AXONService — Net Sales
$397.84M+36.2%

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M
CapEx$413.0K-46.8%
Free cash flow$17.0M

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: AngioDynamics’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 3:42 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-048138
(in thousands)Year ended May 31, 2026 / United StatesYear ended May 31, 2026 / InternationalYear ended May 31, 2026 / TotalYear ended May 31, 2025 / United StatesYear ended May 31, 2025 / InternationalYear ended May 31, 2025 / Total
Net sales
Med Tech$129,830$20,124$149,954$109,254$17,399$126,653
Med Device145,09325,127170,220141,72924,116165,845
Total$274,923$45,251$320,174$250,983$41,515$292,498

Item 15. Exhibits, Financial Statement Schedules.

FAQ

What is AngioDynamics's med device — net sales?
AngioDynamics (ANGO) reported med device — net sales of $44.85M in Q1 2026.
How has AngioDynamics's med device — net sales changed year-over-year?
AngioDynamics's med device — net sales increased by 1.1% year-over-year, from $44.37M to $44.85M.
What is the long-term trend for AngioDynamics's med device — net sales?
Over 4 years (2022 to 2026), AngioDynamics's med device — net sales has grown at a -8.0% compound annual growth rate (CAGR), from $237.5M to $170.22M.
What does med device — net sales mean?
Net sales for the medical device segment reflect the total revenue generated from the sale of medical, surgical, and diagnostic devices after accounting for returns, allowances, and discounts. This metric is the primary indicator of market demand and the segment's top-line growth trajectory. It provides insight into the company's ability to capture market share within the competitive healthcare technology landscape.

Ask your AI about AngioDynamics's med device — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude